Efficacy, Safety, and Tolerability of an Intramuscular Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Bipolar I Patients
Clinical trial NCT01567527 · COMPLETED
Trial details
- NCT number
- NCT01567527
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-08-01
- Primary completion
- 2016-04-01
- Enrollment
- 731
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.